Professor of Clinical Psychiatry
Norwich, UNITED KINGDOM
His main areas of work are in ageing brain care, improving memory & cognitive decline, & researching side effects of medicines on the brain.
Eastern Daily Press online
The trial is led nationally by the University of Sussex, with local leadership from Professor Chris Fox at the University of East Anglia in conjunction with the research team at the Norfolk and Suffolk NHS Foundation Trust.view more
Country Living online
Speaking to Mail Online, Professor Chris Fox, a senior lecturer in old age psychiatry at the University of East Anglia, said: “The brain is processing and filing memories away from the day while we are asleep and clearing away toxins. If these toxins are not cleared, this can lead to inflammation in the body. Although inflammation is generally a beneficial response to tissue damage or infection, when it is extensive or prolonged, it can harm healthy tissues and disrupt normal cellular function.view more
Health Europa online
Lead researcher Professor Chris Fox, from UEA’s Norwich Medical School, said: “Around half of people with dementia have trouble sleeping, wake often and wander during the night. This can greatly affect their quality of life and that of the people who care for them. “Z-drugs are commonly prescribed to help treat insomnia but it is thought that they may cause increased confusion and other problems such as falls and fractures.view more
Health Day online
"Around half of people with dementia have trouble sleeping, wake often and wander during the night. This can greatly affect their quality of life and that of the people who care for them," explained lead researcher Chris Fox, from Norwich Medical School at the University of East Anglia in Great Britain.view more
ITV News online
Dr Chris Fox from the university is leading a five-year study which began last year. When completed, it could set guidelines for training staff as well as giving patients and their families a clearer idea of what care to expect.view more
Trials are at risk of contamination bias which can occur when participants in the control group are inadvertently exposed to the intervention. This is a particular risk in rehabilitation studies where it is easy for trial interventions to be either intentionally or inadvertently adopted in control settings.
People living with dementia in care homes frequently exhibit “behaviour that challenges”. Anti-psychotics are used to treat such behaviour, but are associated with significant morbidity. This study researched the feasibility of conducting a trial of a full clinical medication review for care home residents with behaviour that challenges, combined with staff training.
We identified studies published between January 2002 and April 2018 with ≥12 weeks follow-up between strongly anticholinergic drug exposure and the study outcome measurement.
Many publications on dementia start by outlining the current estimated number of people with dementia and how that figure is going to double (in Western societies) or even quadruple (in developing countries) in the coming decades as a result of increasing life expectancy (in itself a good development). Dementia is therefore a huge challenge to society, both in terms of providing good care for persons living with dementia and their family caregivers, as well as in searching for curative solutions.
Within health and social care, academic attention is increasingly paid to understanding the nature and centrality of body work. Relatively little is known about how and where body work specifically fits into the wider work relations that produce it in healthcare settings.